Cleared Special

K991080 - ACCUSIGN MTD, BIOSIGN MTD (FDA 510(k) Clearance)

Apr 1999
Decision
20d
Days
Class 2
Risk

K991080 is an FDA 510(k) clearance for the ACCUSIGN MTD, BIOSIGN MTD. This device is classified as a Enzyme Immunoassay, Methadone (Class II - Special Controls, product code DJR).

Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on April 15, 1999, 20 days after receiving the submission on March 26, 1999.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3620.

Submission Details

510(k) Number K991080 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 1999
Decision Date April 15, 1999
Days to Decision 20 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code DJR — Enzyme Immunoassay, Methadone
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3620